baber/WOPTO huggingface dataset:
Patent IL-85773-A0 (IL)
Title: 19,11 beta-bridged steroids,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07J21/00
Filed: 1988-03-17
Abstract: New 19,11 beta -bridged steroids of the general formula I   <IMAGE> (I)  where R1 stands for a methyl or ethyl radical, R2 for a hydrogen or chlorine atom or a C1-C4-alkyl radical, B and G, which are the same or different, respectively for a hydrogen atom, a C1-C4-alkyl radical or, together, for a second bond between the carbon atoms 6 and 7, B and R2 together for a methylene or an ethylene group, Z for the radical of a pentagonal or hexagonal ring, which is possibly substituted and possibly unsaturated, V stands for a possibly substituted carbocyclic or heterocyclic aryl radical, the ring A for <IMAGE> a)   M and N together meaning a second bond or M a hydrogen atom and N a hydroxy group, X means an oxygen atom, two hydrogen atoms or a hydroxyimino grouping N DIFFERENCE OH, R3 and D, which are the same or different, respectively a hydrogen atom, a nitrile radical or a C1-C4-alkyl radical or, together, a methylene or ethylene group, E a hydrogen atom or a C1-C4-alkyl radical, D and E together meaning a second bond between carbon atoms 1 and 2 or together a methylene group   <IMAGE> b)  or  <IMAGE> c)   with R11 in the meaning of a hydrogen atom or a C1-C8-alkyl radical, are described as well as their pharmaceutically tolerated addition salts with acids. The new compounds possess valuable pharmacological properties.
Patent IL-97692-A0 (IL)
Title: Yeast strains with enhanced trehalose content,their production and their use
IPC: C12R1/865
Filed: 1991-03-27
Abstract: A transformed yeast is disclosed, comprising at least one gene encoding neutral trehalase or trehalose-6-phosphate synthase which gene has been modified such that it differs from a corresponding wild-type gene encoding neutral trehalase or trehalose-6-phosphate synthase, the yeast having as a result a different trehalose content from the untransformed parent yeast. The sugar resistance and drying resistance of the yeast compared to those of the untransformed strain are thereby improved.
Patent IL-99067-A0 (IL)
Title: Hydrodynamic bearings
IPC: F16C17/00
Filed: 1991-08-02
Abstract: A hydrodynamic thrust, journal or combined radial and thrust bearing which may be mounted within a sealed housing assembly (1) which can, for example, be used to replace rolling element bearings. The bearing can be designed for mounting to either the shaft or housing. If mounted for rotation with the shaft, the bearing pads (12) move relative to a smooth support surface. The bearing includes a bearing pad structure (1, 14, 126) that may change shape and move in any direction (six degrees of freedom) to optimize formation of a converging wedge for hydrodynamic operation, equalization of load on the bearing pads (12) in thrust bearings and to adjust for any shaft misalignment.
Patent FI-20031020-A0 (FI)
Inventor: VARPELA PERTTELI
IPC: G16B5/10
Filed: 2003-07-04
Abstract: An information management system for managing biochemical information (200). The biochemical information (200) comprises data sets (202) and each data set comprises a variable value matrix containing variable values organized as rows and columns; a row description list, in a variable description language, of the rows in the variable value matrix; a column description list, in a variable description language, of the columns in the variable value matrix; and a fixed dimension description, in a variable description language, of one or more fixed dimensions that are common to all values in the variable value matrix. A benefit achieved by storing the numerical values as a scalar matrix is that the matrix can be analyzed with many commercially available data-mining tools, such as self-organizing maps or other clustering algorithms, that do not readily process dimensioned values.
Patent FI-20040392-A0 (FI)
Inventor: LAPPETELAEINEN ANTTI
IPC: H04W88/04
Filed: 2004-03-12
Abstract: A subscriber terminal holding a subscriber identity is connected to a sub-terminal using the identity of the subscriber terminal over a wireless proximity interface. A radio link directed from an infrastructure to the sub-terminal is requested by the subscriber terminal, and at least a portion of signalling between the sub-terminal and the wireless telecommunications infrastructure is routed via the subscriber terminal.
Patent IL-106647-A0 (IL)
Title: Aqueous dispersions of zein and controlled release coatings derived therefrom
IPC: C08J3/07
Filed: 1993-08-10
Abstract: Stable aqueous dispersions of zein which may be used as controlled release coatings of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.
Patent IL-107255-A0 (IL)
Title: Chewable pharmaceutical compositions
IPC: A61P43/00
Filed: 1993-10-12
Abstract: The present invention relates to the use of 10 to 150mg ranitidine in the treatment of minor conditions where there is an advantage in lowering gastric acidity.
Patent IL-111483-A0 (IL)
Title: Process for the preparation of etoposide phosphate and etoposide and certain such novel intermediate compounds
IPC: A61K31/7042
Filed: 1994-11-01
Abstract: Etoposide phosphate is prepared by coupling dibenzyl 4'-demethyl-4-epipodophyllotoxin-4'-phosphate with 2,3-di-O-benzyl-4,6-O-ethylene- alpha , beta -D-glucopyranose in a solvent and subsequently removing the protecting groups. The tetra-benzyl protected etoposide phosphate is recrystallized from methanol or directly crystallized from acetonitrile by adding methanol to yield substantially the pure C-1''- beta  form. The benzyl protecting groups are simultaneously removed by hydrogenation to produce etoposide phosphate in high yields. In a further embodiment, etoposide phosphate is treated with a phosphatase enzyme to yield etoposide.
Patent IL-112440-A0 (IL)
Title: Process for the preparation of arylacetic ester derivatives
IPC: C07D317/46
Filed: 1995-01-25
Abstract: PCT No. PCT/EP95/00146 Sec. 371 Date Jul. 22, 1996 Sec. 102(e) Date Jul. 22, 1996 PCT Filed Jan. 16, 1995 PCT Pub. No. WO95/20569 PCT Pub. Date Aug. 3, 1995Process for the preparation of 2-methoxyimino-2-arylacetic esters of formula (I) in which R is C1-C12alkyl, which comprises reacting an appropriately substituted boronic acid of general formula (II) or the trimeric form (lII) herein, which is in equilibrium with it, in the presence of a Pd catalyst, with a methoxyiminoacetic ester of formula (IV) in which R is C1-C12alkyl and X is a leaving group. According to a further process variant, in principle the groups which split off the two reactants may change places. The process can be applied not only to phenyl derivatives but also to larger ring systems (naphthyl, pyridyl, heterocycles).
Patent IL-113954-A0 (IL)
Title: Packaging arrangement
IPC: B65B55/02
Filed: 1995-05-31
Abstract: The present invention relates to a packaging arrangement for packaging contact lenses in blister packs. The arrangement has a movable support base defining on its upper surface a plurality of identical support pallets (14), equally spaced apart along the support base. Each support pallet is designed to support an array of individual package bases (16) and is sequentially stopped: at a first position, for receiving blister package bases having a lens therein: and at subsequent positions for verification, alignment, saline deposition, saline verification, covering, heat sealing and unloading. <IMAGE>
Patent IL-125839-A0 (IL)
Title: Uses of gdnf and gdnf receptor
IPC: A61K38/00
Filed: 1997-03-13
Abstract: GDNFRα, GDNFRα extracellular domain (ECD), GDNFRα variants, chimeric GDNFRα (e.g., GDNFRα immunoadhesin), and antibodies which bind thereto (including agonist and neutralizing antibodies) are disclosed. Various uses for these molecules are described, including methods to modulate cell activity and survival by response to GDNFRα-ligands, for example GDNF, by providing GDNFRα to the cell. Also provided are methods for using GDNFRα, GDNF, or agonists thereof, separately or in complex, to treat kidney diseases.
Patent IL-138752-A0 (IL)
Title: Modular motorized electric wheel hub assembly for bicycles and the like
IPC: B62M6/45
Filed: 1999-04-21
Abstract: A motorized wheel hub assembly includes a sealed motor section having first and second coaxial shafts extending from the motor section, the second shaft being a rotary shaft and a gear reduction section adjacent to the motor section, the gear reduction section including a pinion at the end of the rotary shaft, a plurality of planet gears rotatably mounted to the housing in meshing engagement with the pinion and a third shaft connected to the motor housing, all of the shafts being separate but coaxial. A hub having an interior surface closely surrounds the motor and gear reduction sections and is rotatably coupled to the first and third shafts. A ring gear formed in the interior surface of the hub is in meshing engagement with the planet gears so that when the second shaft rotates at a selected speed, the hub rotates relative to the first and third shafts at a lesser speed. Preferably, the hub is partially filled with oil to conduct heat from the motor section to the outside.
Patent IL-142905-A0 (IL)
Title: Functional antagonists of hedgehog activity
IPC: C12N15/09
Filed: 1999-11-02
Abstract: Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence lacking the ability to elicit a hedgehog-dependent response in C3H 10T1/2 cells but having the ability to bind to the hedgehog receptor, patched-1. Methods for producing such functional antagonists and methods of using the functional antagonists are also described.
Patent IL-156796-A0 (IL)
Title: Nonabrasive media with accelerated chemistry
IPC: B24B31/14
Filed: 2002-01-07
Abstract: The invention is an improvement in the metal finishing processes disclosed in U.S. Pat. No. 4,818,333. The improvement arises in the use of nonabrasive media, such as stainless steel or plastic, in combination with chemicals that are reactive to the metal surface processed. The invention also includes metal articles finished using this process.
Patent IL-160029-A0 (IL)
Title: Receptor, the use thereof, and mouse antibodies
Inventor: MULLER-HERMELINK HANS-KONRAD
IPC: A61P35/00
Filed: 2002-07-23
Abstract: Glycoprotein receptor (I), present on the surface membrane of strongly proliferating cells, especially stomach carcinoma, having at least one determinant that corresponds with a determinant of CFR-1 protein, and binding specifically to human antibody 103/51 and/or the murine antibody 58/47-69 (immunoglobulin M), is new. Independent claims are also included for: (1) method for isolating (I); (2) murine antibody 58/47-69; and (3) preparing an antitumor agent using antibodies specific for (I). ACTIVITY : Cytostatic; Antibacterial; Antiinflammatory. No biological data is given. MECHANISM OF ACTION : Vaccine; Receptor antagonism.
Patent IL-165002-A0 (IL)
Title: Method and system for distributing documents
IPC: G06F3/041
Filed: 2004-11-03
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent IL-169785-A0 (IL)
Title: An elevator rope
IPC: D07B1/16
Filed: 2005-07-20
Abstract: An elevator rope comprising an elastomer coated, multistrand steel wire cable is claimed. In such a cable strands have a lay-length of at least 6.5 times the diameter of the bare cable diameter D. The cable is further coated with an elastomeric jacket, which adheres to the strands with a pull-out force not less than 15xD+15 newton per mm. The advantages of such an elevator rope are amongst others its limited elongation, its reduced diameter and its improved fatigue life.
Patent IL-174130-A0 (IL)
Title: Gas phase oxidation catalyst with defined vanadium oxide particle size distribution
IPC: C07C51/265
Filed: 2006-03-06
Abstract: A process is described for producing a catalyst for gas-phase oxidations, in which a suspension of TiO2 and V2O5 particles is applied to a fluidized inert support, wherein at least 90% by volume of the V2O5 particles have a diameter of 20 mum or less and at least 95% by volume of the V2O5 particles have a diameter of 30 mum or less. The defined particle size distribution of the V2O5 allows a high coating efficiency.
Patent IL-186153-A0 (IL)
Title: Methods and compositions for inhibiting neoplastic cell growth
IPC: C12R1/91
Filed: 2007-09-20
Abstract: The present invention concerns methods and compositions for inhibiting neoplastic cell growth. In particular, the present invention concerns antitumor compositions and methods for the treatment of tumors. The invention further concerns screening methods for identifying growth inhibitory, e.g., antitumor compounds. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent IL-188525-A0 (IL)
Title: Projection of subsurface structure onto an object's surface
Filed: 2008-01-01
Abstract: An imaging system illuminates an object with infrared light to enhance visibility of buried structure beneath the surface of the object, and projects a visible light image of the buried structure onto the surface of the object. The system may include an infrared light source for generating the infrared light and a structure for diffusing the infrared light. The diffusing structure may include one or more layers of diffusing material for diffusing the light. The system further includes a video imaging device for receiving the infrared light reflected from the object and for generating a video image of the buried structure based on the reflected infrared light. The buried structure may be a subcutaneous blood vessel. A calibration procedure is described as well as embodiments for ensuring that the object is maintained in focus at the correct distance.
Patent RO-136028-A0 (RO)
Title: Graphene materials functionalized with platinum and non-polluting process for producing the same
Inventor: OUBRAHAM ANIŞOARA
IPC: C01B32/198
Filed: 2022-05-02
Abstract: The invention relates to graphene materials functionalized with platinum in a microwave field in an acidic medium and to a process for producing the same, the graphene materials being meant to be used for the development of new types of hydrophobic catalysts, active and stable in highly radioactive environments in the presence of moisture. According to the invention, the graphene materials are prepared from graphene oxide functionalized with platinum, starting from a solution of hexachloroplatinic acid as a precursor of platinum in an acidic medium and have the highest concentration of functionalization with platinum of 4.7% by weight, having a specific surface area of 228 m2/g and high porosity. According to the invention, the production process has a working methodology in a single reaction step consisting in mixing the ultrasonically-treated suspension of graphene oxide with a non-polluting reducing agent, namely ethylene glycol, and a platinum precursor, hexachloroplatinic acid, the mixture thus obtained being introduced into a microwave field of 800 W in an acidic medium at a temperature of 180°C.
Patent AU-2002951675-A0 (AU)
Title: Automated belt cooking machine for pancakes or the like
IPC: A21B1/48
Filed: 2001-11-19
Abstract: An automated belt cooking machine (10) for pancakes and the like food products has upper and lower overlapping, thermally conductive belts (12, 14), counter-rotatably mounted to a frame (16) so that, in use, a bottom run (30) of the upper belt (12) and a top run (32) of the lower belt (14) co-operate to convey food (40) to be cooked. The lower belt (14) extends a predetermined distance to one side of the upper belt (12) so as to provide a dispensing platform portion (38) for dispensing thereon the food to be cooked (40), so that the food (40) is conveyed towards a mouth (52) formed between the upper belt and lower belts (12, 14) and thereafter is conveyed sandwiched between the bottom and top run (30, 32). Upper and lower heating platens (26,28) are mounted to the frame (16) and are in thermal contact with the bottom and top run (30, 32), wherein the food to be cooked (40) is initially exposed to heat from the lower platen (28) conducted through the dispensing platform portion (38).
Patent CU-21888-A1 (CU)
Title: Método para la obtención de una vacuna de amplio espectro protector contra la nisseria meningitidis del grupo b y la vacuna resultante
Inventor: GARCIA IMIA LUIS GUILLERMO
IPC: A61K39/095
Filed: 1987-07-30
Abstract: Con el objetivo de disponer de un preparado vacunal efectivo contra la meningitis meningococica del Grupo B se desarrolla todo un procedimiento de preparación de sus componentes así como de la obtención final de la vacuna para la profilaxis y prevención de esta enfermedad. Se describe el método de obtención de las proteínas de la membrana externa y del polisacárido capsular de la Neisseria Meningitidis, y del Gel de hidróxido aluminio empleado como coadyuvante en la vacuna, así como procedimiento de conjugación y adsorción de los mismos. Aplicable en el campo de la medicina, en la rama de la industria médico farmacéutica de biopreparados.
Patent LU-86279-A1 (LU)
Inventor: DEBRAS GUY L G
IPC: C01B33/18
Filed: 1986-01-29
Abstract: 1. Process for stabilizing the activity of crystalline silica polymorph of the TEA-silicate type used as hydrocarbons conversion catalyst, characterized in that it consists of : a) halogenating said TEA-silicate by contacting it with a gaseous stream comprising : (i) an halogenation agent selected from the group comprising the organic saturated aliphatic chlorinated compounds, the organic saturated aliphatic brominated compounds, the organic saturated aliphatic fluorinated compounds and mixtures thereof, having a vapor pressure of at least 13 kPa at a temperature of 200 to 230 degrees C and having an halogen/carbon atomic ratio equal to or higher than 1 ; and (ii) a non-reducing gaseous vehicle ; at a temperature comprised between 200 and 500 degrees C and during a period of time sufficient to fix from 0.1 to 5% by weight of halogen on the TEA-silicate ; b) recovering or using the so-formed stabilized and halogenated TEA-silicate.
Patent LU-88216-A1 (LU)
Inventor: PADOVANI PIETRO DR
IPC: B29C51/08
Filed: 1993-01-27
Abstract: A method for the thermoforming of hollow objects having a base from a sheet of thermoplastics material, which effects in one single predetermined operating cycle, the production of a pressed object by hot forming and cutting out of the object or objects between one half of a movable double female mould which is located in the forming area opposite a male die, movement of the female half of the mould, said half containing therewithin the thermoformed object or objects, towards a corresponding discharge area alternately to one side or the other of the forming area, picking up the object or objects from the female half of the mould located in corresponding discharge area and transferring each object to a plurality of receiving formers of a shape corresponding to the mould, which formers can move sequentially stepwise along a track, sequential movement of the formers to at least one workstation or handling station at the same time as the female mould moves back to place its other half opposite the male die in order to produce a subsequently formed object, and performing at least one processing or handling operation on all the objects carried by at least one former at the same time as the next formed object is produced.
Patent MA-18639-A1 (MA)
Inventor: JEAN-LOUIS CARDINI
IPC: B03B7/00
Filed: 1979-11-12
Abstract: This invention provides a process and apparatus for the wet attrition of ore. The process comprises grinding the ore to a pulp having a particle size distribution such that about 80% by weight of the particles have a diameter of from about 30 to about 0.4 mm; and agitating the pulp in a slightly turbulent medium. The apparatus comprises a vat having top and bottom covers with central openings and a gutter disposed along the exterior circumference of the top of the vat; a cylindrical shaft extending through the opening in the top cover; and a pair of impellers mounted at a distance apart on the shaft, the blades of the impellers being so arranged that the pulp is pumped towards the space defined between the two impellers.
Patent MA-26916-A1 (MA)
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: A61P31/14
Filed: 2002-12-18
Abstract: The present invention provides pharmaceutical compositions for the treatment of a flavivirus or pestivirus infection in a host, wherein the infection is not hepatitis C, comprising an antivirally effective amount of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside or pharmaceutically acceptable salts or esters thereof, in combination with one or more other anti-flavivirus or pestivirus agent. The present invention further provides for the use of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside or pharmaceutically acceptable salts or esters thereof, in the manufacture of a medicament for the treatment of a flavivirus or pestivirus infection in a host, wherein the infection is not hepatitis C.